DPB11 Antibody

What is DPB11 and what is its function in cells?

DPB11 is an essential 87-kDa protein involved in chromosomal DNA replication and S-phase checkpoint function in Saccharomyces cerevisiae (budding yeast). It shares homology with the Schizosaccharomyces pombe rad4+/cut5+ gene product, which has cell cycle checkpoint functions . DPB11 forms part of the DNA polymerase II(epsilon) complex during chromosomal DNA replication and plays a crucial role in the initiation of DNA synthesis.

Disruption of the DPB11 gene is lethal, demonstrating its essential nature for cell proliferation . In temperature-sensitive dpb11-1 mutant cells, S-phase progression becomes defective at non-permissive temperatures, followed by unequal chromosomal segregation and loss of viability . This phenotype highlights DPB11's critical role in ensuring proper DNA replication and chromosome distribution.

DPB11 controls the association between DNA polymerases α and ε and Autonomously Replicating Sequences (ARS), which function as replication origins in yeast . It associates with ARS fragments during S phase, at the same time as DNA polymerase ε, and this association is required for subsequent recruitment of DNA polymerase α-primase to initiate DNA synthesis .

Additionally, DPB11 participates in checkpoint pathways during the S phase to sense stalled DNA replication. Cells with mutations in DPB11 demonstrate sensitivity to DNA damaging agents including hydroxyurea, methyl methanesulfonate, and UV irradiation, underscoring its importance in the cellular response to replication stress .

What techniques are commonly used to study DPB11 protein interactions?

Several sophisticated techniques are employed to investigate DPB11 protein interactions, with co-immunoprecipitation (Co-IP) being particularly valuable. In Co-IP, a target protein is captured using a specific antibody and precipitated using beads, allowing identification of interacting proteins . This approach has revealed that DPB11 physically interacts with DNA polymerase ε (Polε), forming a complex that remains intact even after DNase I treatment, indicating the interaction is not mediated by DNA .

Chromatin Immunoprecipitation (ChIP) has been adapted to study DPB11's association with specific DNA regions. This technique involves cross-linking proteins to DNA in vivo, purifying and sonicating chromatin, and immunoprecipitating with specific antibodies. PCR is then used to amplify DNA sequences from the immunoprecipitates to determine whether DPB11 associates with particular genomic regions, such as ARS fragments . In published protocols, researchers have used anti-HA antibodies (12CA5) for Pol2-3HA and anti-myc antibodies (9E11) for Dpb11-9myc in these assays .

In vitro binding assays provide another approach, where researchers immobilize Dpb11 to beads and incubate it with various proteins to study direct interactions. Studies have shown that CDK-phosphorylated Sld2 binds more efficiently to Dpb11 than non-phosphorylated Sld2 . The specificity of these interactions can be confirmed using peptide competition assays, where phosphorylated peptides are used to compete for binding sites .

Additionally, phosphorylation-specific antibodies that recognize particular phosphorylated forms of proteins (such as anti-pThr84 antibodies for Sld2) have been developed to monitor cell cycle-dependent regulation of protein interactions with Dpb11 . These antibodies can track when specific regulatory phosphorylation events occur during the cell cycle.

What is the role of DPB11 in DNA replication?

DPB11 plays multiple critical roles in DNA replication, particularly during the initiation phase. It controls the association of DNA polymerases with replication origins, as evidenced by chromatin immunoprecipitation (ChIP) assays demonstrating that DPB11 associates preferentially with ARS fragments during S phase, coinciding with DNA polymerase ε (Polε) association . This association is mutually dependent, suggesting that the Dpb11-Polε complex functions as a unit at replication origins.

The importance of DPB11 in replication initiation is demonstrated by several experimental observations. In dpb11-1 mutants, no significant replication bubble arcs are observed by 2D gel analysis, indicating a failure to initiate DNA synthesis . Additionally, DPB11 is required for the association of the Polα-primase complex with ARS fragments, which is essential for initiating DNA synthesis by synthesizing primer RNA .

DPB11 associates with ARS fragments after the assembly of the pre-replication complex (pre-RC) and this association depends on functional Replication Protein A (RPA) . In cells lacking functional DPB11, MCM proteins (components of the pre-RC) do not dissociate from ARS fragments, further supporting DPB11's essential role in triggering the initiation of DNA replication, as MCM proteins normally dissociate when DNA synthesis begins .

Beyond initiation, evidence suggests DPB11 may also function during the elongation phase of replication. S-phase progression is delayed in dpb11-1 cells after hydroxyurea arrest, and short DNA fragments accumulate in dpb11-10 cells at high temperature . Furthermore, DPB11 appears to be involved in regulating late-origin firing in response to replication stress, as dpb11-1 mutants show abnormal association of Polε with late-origin fragments in the presence of hydroxyurea, which normally inhibits late-origin firing .

How is DPB11 activity regulated during the cell cycle?

DPB11 activity is tightly regulated throughout the cell cycle, with particularly important roles during S phase. Co-immunoprecipitation studies have shown that DPB11 forms complexes with DNA polymerase ε (Polε) throughout the cell cycle, but these interactions are most abundant during S phase. When cells were arrested with hydroxyurea (HU) during S phase, Dpb11 was most abundant in the precipitates containing Pol2 (a subunit of Polε) .

Cyclin-dependent kinase (CDK) activity plays a crucial role in regulating DPB11 function. The interaction between DPB11 and other replication proteins, such as Sld2, is controlled by CDK-mediated phosphorylation . Specific phosphorylation events are critical for these interactions. For example, phosphorylation of Thr84 in Sld2 is essential for binding to DPB11, while other phosphorylation sites (like Ser100) are dispensable for this interaction . This phosphorylation occurs at the same time that Sld2 appears in its hyperphosphorylated form during the G1/S transition .

DPB11's association with replication origins is temporally regulated during the cell cycle. ChIP assays have shown that DPB11 associates with ARS fragments specifically during S phase, after the assembly of the pre-replication complex (pre-RC) . This association depends on functional RPA (Replication Protein A), indicating that DPB11 activity is integrated into the broader regulatory network controlling replication origin activation .

What controls should be included when studying DPB11-protein interactions?

When studying DPB11-protein interactions, comprehensive controls are essential to ensure experimental validity. Based on established methodologies in the field, several key controls should be incorporated:

For antibody specificity, researchers should perform immunoprecipitation from strains where the target protein is deleted or depleted when possible, include isotype control antibodies to identify non-specific binding, and validate antibodies by Western blot to confirm they detect a single band of the expected molecular weight .

Genetic controls are particularly valuable, including temperature-sensitive dpb11 mutants (like dpb11-1) to confirm that observed interactions are specific and functional . The search results demonstrate that dpb2-1 cells showed defective Dpb11-Polε complex formation and can serve as a negative control for this interaction . For phosphorylation-dependent interactions, phospho-site mutants should be included, as demonstrated with the T84A mutation in Sld2 .

DNA dependency controls are crucial to determine whether interactions are direct protein-protein interactions or mediated by DNA. The search results note that the Dpb11-Pol2 complex remained intact after DNase I treatment, suggesting it's not bridged by DNA fragments . Similarly, RNase treatment can rule out RNA-mediated interactions.

Cell cycle controls should include appropriate synchronization verification through Western blots for known cell cycle phase markers and FACS analysis to verify cell cycle distribution in synchronized populations . Different synchronization methods (α-factor for G1, HU for S, nocodazole for M phase) can be used to study cell cycle-dependent interactions .

Reciprocal co-immunoprecipitation provides additional validation by demonstrating that interactions can be detected by precipitating either partner. For phosphorylation-dependent interactions, phosphatase treatment and CDK inhibition serve as important controls. The search results show that expressing a stable form of the CDK inhibitor Sic1 prevented Thr84 phosphorylation of Sld2 .

When studying DPB11's role in replication, include PCR amplification of non-origin (non-ARS) fragments as negative controls for origin-specific binding to distinguish between specific and non-specific DNA associations .

How can I optimize co-immunoprecipitation protocols for studying DPB11 protein complexes?

Optimizing co-immunoprecipitation (Co-IP) protocols for DPB11 protein complexes requires careful consideration of multiple parameters to maximize specificity and sensitivity. Based on published research methodologies, several key optimization strategies can be implemented:

Cell synchronization strategies

DPB11 interactions vary throughout the cell cycle, with Dpb11-Pol2 co-immunoprecipitation most abundant in hydroxyurea-arrested (S phase) cells . For comprehensive analysis, synchronize cells at specific stages:

• α-factor for G1 phase arrest

• Hydroxyurea for S phase arrest

• Nocodazole for M phase arrest

This approach allows detection of cell cycle-dependent interactions, providing insights into the temporal regulation of DPB11 complexes.

Antibody selection and validation

For untagged proteins, highly specific antibodies against DPB11 are required. Alternatively, tagged versions have been successfully employed, with anti-HA antibodies (12CA5) for Pol2-3HA and anti-myc antibodies (9E11) for Dpb11-9myc showing good results . Validate antibody specificity with appropriate controls, including isotype controls and immunoprecipitation from cells lacking the target protein.

Optimizing extraction conditions

The lysis buffer composition significantly impacts complex preservation. Consider testing different detergents and salt concentrations to optimize extraction while maintaining interactions. DNase I treatment helps determine if protein-protein interactions are direct or DNA-mediated. Research has shown that the Dpb11-Pol2 complex remained intact after DNase I treatment, indicating a direct protein-protein interaction .

Detecting weak interactions

For challenging interactions, increasing protein concentration by using more cells can improve detection. This approach was described when investigating Dpb11-Polε complex formation in dpb2-1 cells, where researchers used five times the number of cells to try to detect the interaction . Despite this approach, the interaction remained undetectable in dpb2-1 cells, confirming the DPB2 gene product's importance for complex formation.

Incorporating appropriate controls is essential, including negative controls (immunoprecipitation with irrelevant antibodies) and using mutant strains with known defects in complex formation (e.g., dpb2-1 cells) as reference points . For phosphorylation-dependent interactions, phosphatase-treated samples provide valuable controls .

For detection, Western blotting with specific antibodies against complex components remains the standard approach, though sensitivity can be enhanced through optimized antibody dilutions and exposure times.

What technical challenges exist when using DPB11 antibodies in ChIP assays?

Chromatin Immunoprecipitation (ChIP) assays with DPB11 antibodies present several technical challenges that require specific optimization strategies. Based on published protocols and research findings, these challenges and their solutions include:

Antibody reactivity after cross-linking

A significant challenge documented in the literature is that after formaldehyde treatment, anti-DPB11 antibodies show reduced reactivity with DPB11 in whole-cell extracts . This occurs because formaldehyde creates protein-protein and protein-DNA cross-links that may mask antibody epitopes.

To address this issue, researchers should optimize cross-linking conditions by titrating formaldehyde concentration and exposure time. Despite reduced reactivity in whole-cell extracts, the research indicates that anti-DPB11 antibodies can still detect precipitated DPB11 , suggesting that proceeding with the ChIP protocol can still yield meaningful results.

Cell synchronization requirements

DPB11 associates with replication origins in a cell cycle-dependent manner, primarily during S phase . Failure to properly synchronize cells will lead to diluted signals and potentially misleading results.

Published protocols have addressed this by precisely synchronizing cells (using α-factor arrest and release) and collecting samples at specific time points. To facilitate detection, researchers have released cells at 16°C to slow the movement of the replication fork, making it easier to detect transient associations at replication origins . FACS analysis should be performed to confirm synchronization efficiency.

Resolution limitations

Standard ChIP protocols involve sonication to create ~500 bp DNA fragments, limiting resolution to approximately this size. As noted in the research, this makes it impossible to determine whether DPB11 associates directly with the ARS sequence (~100 bp) or the surrounding region .

PCR optimization

PCR amplification from ChIP samples requires careful optimization to avoid biases and ensure accurate quantification. The published protocol describes setting up PCR conditions to amplify each fragment evenly from total genomic DNA by adjusting the final concentration of each primer .

Multiple genomic regions should be included in the same PCR reaction to provide internal controls. The protocol successfully used three pairs of primers together in each PCR, with primers for two ARS fragments (ARS1 and ARS305) and one non-ARS fragment in the CYC1 gene . This approach provides built-in controls for specificity of DPB11 association with replication origins.

Appropriate controls

Comprehensive controls are essential for interpreting ChIP results. These should include no-antibody controls to assess non-specific binding to beads, input DNA controls (typically 1/6,000 of cross-linked DNA from whole-cell extract as used in the referenced protocol) , untagged strain controls when using tagged proteins, and non-ARS fragments (e.g., CYC1 gene regions) as negative controls for ARS-specific binding .

Additionally, genetic controls using mutant strains provide valuable insights into the dependencies of DPB11 association with chromatin. The research utilized rfa2-2, dpb2-1, and cdc17-1 mutants to establish that DPB11 association with ARS fragments depends on functional RPA and Polε, but not on Polα .

How do mutations in DPB11 affect its interaction with DNA polymerase epsilon?

Mutations in DPB11 significantly impact its interaction with DNA polymerase epsilon (Polε), with profound consequences for DNA replication and cell viability. Multiple lines of evidence from genetic and biochemical studies reveal the nature of these effects:

Temperature-sensitive dpb11-1 mutation was initially identified as a suppressor of mutations in essential subunits of DNA polymerase epsilon (POL2 and DPB2) . At non-permissive temperatures, dpb11-1 cells exhibit defective S-phase progression, followed by unequal chromosomal segregation and loss of viability , indicating compromised Polε function.

Genetic interaction analysis reveals synthetic lethality between dpb11-1 and mutations in Polε subunits (dpb2-1, pol2-11, and pol2-18) at all temperatures . This synthetic lethality indicates that when both proteins are partially compromised, their interaction becomes insufficient to support essential DNA replication functions, resulting in cell death.

Chromatin immunoprecipitation (ChIP) assays demonstrate that in dpb11-1 cells, Polε fails to properly associate with ARS fragments . Since DPB11 and Polε association with ARS fragments is mutually dependent , mutations disrupting one protein's association with replication origins also affect the other, highlighting their interdependent relationship at replication origins.

These findings collectively demonstrate that DPB11 mutations can affect Polε function through multiple mechanisms: disrupting physical complex formation, preventing proper localization to replication origins, and interfering with checkpoint-dependent regulation of Polε activity.

What are the best experimental approaches to study DPB11's role in checkpoint pathways?

Studying DPB11's role in checkpoint pathways requires multifaceted experimental approaches that integrate genetic, cell biological, and molecular techniques. Based on published methodologies, the following comprehensive strategy is recommended:

Genetic approaches

Temperature-sensitive dpb11 mutants (such as dpb11-1) provide controlled inactivation of DPB11 function and are valuable tools for studying checkpoint defects . These mutants can be combined with mutations in known checkpoint genes through synthetic lethality screening and epistasis analysis to identify genetic interactions and establish pathway relationships.

Research has demonstrated synthetic lethality between dpb11 mutations and mutations in essential replication genes (POL2, DPB2) , suggesting integrated roles in DNA replication and checkpoint functions. By creating double mutants between dpb11 and checkpoint genes (RAD53, MEC1), researchers can determine the hierarchy of function in checkpoint pathways.

Cell biology approaches

FACS (Fluorescence-Activated Cell Sorting) analysis enables examination of how dpb11 mutations affect cell cycle progression after DNA damage or replication stress . This approach reveals checkpoint defects by identifying abnormal cell cycle distributions.

DNA damage sensitivity assays provide direct evidence of checkpoint function. Published research has tested sensitivity of dpb11 mutants to various DNA damaging agents including hydroxyurea (HU), methyl methanesulfonate (MMS), and UV irradiation . These assays can be quantified by comparing survival rates at different doses of damaging agents.

Chromosome segregation analysis is particularly relevant since dpb11-1 cells show unequal chromosomal segregation at non-permissive temperatures , indicating checkpoint failure in preventing mitosis with incompletely replicated DNA.

Molecular biology approaches

ChIP assays have been successfully employed to examine DPB11 association with early- and late-firing origins under checkpoint-activating conditions. A key finding from this approach is that in wild-type cells treated with HU, Polε associates only with early-origin fragments, while in dpb11-1 cells, Polε associates with both early and late origins . This reveals DPB11's role in the regulation of late-origin firing during checkpoint activation.

2D gel electrophoresis provides visualization of replication intermediates to determine how dpb11 mutations affect origin firing and fork progression during checkpoint activation . This technique can identify abnormal replication structures that form when checkpoints fail.

S-phase progression analysis after HU arrest has revealed that dpb11-1 cells show delayed progression , suggesting checkpoint recovery defects. This approach involves releasing cells from HU arrest and monitoring DNA content by FACS and replication progression by molecular techniques.

Biochemical approaches

Co-immunoprecipitation experiments comparing DPB11 protein interactions under normal versus checkpoint-activating conditions (e.g., HU treatment) can identify checkpoint-specific interactions . This approach has demonstrated that Dpb11-Pol2 interaction is most abundant in HU-arrested cells .

For all these approaches, appropriate controls are essential: include known checkpoint mutants (rad53, mec1) as positive controls for checkpoint defects , use wild-type strains as negative controls, and validate key findings using multiple independent assays.

This integrated experimental strategy provides comprehensive insights into DPB11's multifaceted roles in checkpoint pathways, from sensing replication stress to regulating origin firing and ensuring genomic stability.

How can phosphorylation state-specific antibodies be used to study DPB11 regulation?

Phosphorylation state-specific antibodies represent powerful tools for dissecting the regulatory mechanisms controlling DPB11 function throughout the cell cycle. Based on established methodologies, these specialized antibodies can be employed in several sophisticated approaches:

Monitoring cell cycle-dependent phosphorylation events

Phospho-specific antibodies enable precise tracking of when specific regulatory phosphorylation events occur during the cell cycle. This approach has been successfully demonstrated with anti-pThr84 antibodies for Sld2, a DPB11-interacting protein .

The methodology involves synchronizing cells using α-factor arrest and release, collecting samples at defined time points, and analyzing by Western blotting with phospho-specific antibodies. Research has shown that Thr84-phosphorylation of Sld2 occurred at the same time as the slow-migrating (hyperphosphorylated) form appeared in SDS-PAGE after release from G1 arrest , correlating phosphorylation with cell cycle progression.

Correlating phosphorylation with protein mobility shifts

While protein mobility shifts in SDS-PAGE often indicate phosphorylation, multiple phosphorylation sites can complicate interpretation. Phospho-specific antibodies distinguish which specific phosphorylation events correspond to observed mobility shifts.

Experimental evidence demonstrates that when cells were arrested in G1 phase by α-factor and released, the slow migrating form of Sld2 (hyperphosphorylated) appeared concurrently with Thr84-phosphorylation . This approach clarifies which specific phosphorylation events are responsible for mobility shifts observed during cell cycle progression.

Analyzing CDK-dependent regulation

Many DPB11 interactions are regulated by cyclin-dependent kinase (CDK) activity. Phospho-specific antibodies can determine which sites are CDK-dependent by comparing phosphorylation in normal cells versus cells with inhibited CDK activity.

Research has shown that neither the slow migrating form of Sld2 nor Thr84 phosphorylation was observed in cells expressing a stable form of the CDK inhibitor Sic1 (Sic1ΔNT) . This approach definitively establishes CDK dependency of specific phosphorylation events.